News
Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the executive management team will participate in a fireside chat at the (virtual) SVB Leerink
SunOpta Inc. Schedules Fourth Quarter 2020 Financial Results Release and Conference Call
SunOpta Inc. ("SunOpta") (Nasdaq:STKL) (TSX:SOY) announced today that it will issue financial results for the fourth quarter 2020 before the markets open on Wednesday, March 3, 2021.
Following
Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that it will release its fourth quarter and year end 2020 financial results on Wednesday, February 24, 2021
Sandstorm Gold Royalties Announces 2020 Annual Results
Sandstorm Gold Ltd. (“Sandstorm Gold Royalties,” “Sandstorm” or the “Company”) (NYSE: SAND, TSX: SSL) has released its results for the fourth quarter and year ended December 31, 2020 (all figures
SunOpta Announces Oaktree Exchanges Preferred Equity for Common Stock
SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a leading healthy food and beverage company focused on plant-based foods and beverages and fruit-based foods and beverages, today
Sandstorm Gold Royalties To Release 2020 Fourth Quarter and Annual Results on February 11
Sandstorm Gold Ltd. (“Sandstorm Gold Royalties”) (NYSE: SAND, TSX: SSL) will release its 2020 fourth quarter and annual results on Thursday, February 11, 2021 after markets close.
A conference
SunOpta Advances Strategic Plan With Two New Initiatives
SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a leading healthy food and beverage company focused on plant-based foods and beverages and fruit-based foods and beverages, today
FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved LUPKYNISTM (voclosporin) in
Sandstorm Gold Royalties Provides Asset Update
Sandstorm Gold Ltd. (“Sandstorm Gold Royalties”, “Sandstorm” or the “Company”) (NYSE: SAND, TSX: SSL) is pleased to provide an asset update of recent developments from the Company’s royalty
Sandstorm Gold Royalties Announces Record Revenue in 2020
Sandstorm Gold Ltd. (“Sandstorm Gold Royalties” or the “Company”) (NYSE: SAND, TSX: SSL) is pleased to report that the Company has sold approximately 52,200 attributable gold equivalent ounces1 and
Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences and
SunOpta Announces Completion of Global Ingredients Sale, Full Redemption of $223.5MM 9.5% Senior Second Lien Notes and Signing of a New $250MM Asset-Based Credit Facility with a $75MM Term Loan
SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a leading company focused on plant-based foods and beverages and fruit-based foods and beverages, today announced completion of
Aurinia gibt Kooperations- und Lizenzvertrag mit Otsuka Pharmaceutical Co., Ltd. über die Entwicklung und Vermarktung von Voclosporin in Europa und Japan bekannt
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) („Aurinia“ oder das „Unternehmen“) gab heute den Abschluss eines Kooperations- und Lizenzvertrags mit Otsuka Pharmaceutical Co., Ltd. über die
Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced it has entered into a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. for
Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia”) and Lonza Ltd. (SIX: LONN) ("Lonza") today announced they have expanded their exclusive manufacturing relationship. The parties
Aurinia Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Presentations will be
Aurinia Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company, today announced that the Company’s Compensation Committee granted
First Majestic geht gegen Entscheidung des Kreisgerichts über Nichtigerklärung des „Advance Pricing Agreement“ in Berufung
Vancouver, BC, Kanada - First Majestic Silver Corp. („First Majestic“ oder das „Unternehmen“) hat heute bekannt gegeben, dass seine mexikanische Tochtergesellschaft Primero Empresa Minera,
First Majestic to Appeal Circuit Court Decision to Nullify APA
Vancouver, BC, Canada – First Majestic Silver Corp. ("First Majestic" or the "Company") announced today that its Mexican subsidiary Primero Empresa Minera, S.A. de C.V. (“PEM”) has now been
Aurinia Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the senior management team will participate in a fireside chat during the 2020 Jefferies
Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational Highlights
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”) today reported financial results for the third quarter ended September 30, 2020 and provided an update on recent
SunOpta Announces Agreement to Sell Its Global Ingredients Segment to Amsterdam Commodities N.V.
SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a leading global company focused on plant-based foods and beverages, fruit-based foods and beverages, and organic ingredient
Aurinia Presents Integrated Time to Renal Response Data from the AURA-LV and AURORA Trials, along with Voclosporin Drug-Drug Interaction Data at ACR Convergence 2020
Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) (Aurinia or the Company), a late-stage clinical biopharmaceutical company, today announced data from an integrated analysis of the AURA-LV and
First Majestic Reports Third Quarter Financial Results – Generates Record Revenues, Cash Flows and Earnings
Vancouver, BC, Canada - FIRST MAJESTIC SILVER CORP. (AG: NYSE; FR: TSX) (the "Company" or “First Majestic”) is pleased to announce the unaudited interim consolidated financial results of the
First Majestic meldet Finanzergebnis für das dritte Quartal und erzielt Umsätze, Cashflow und Erträge in Rekordhöhe
Vancouver, BC, Kanada - FIRST MAJESTIC SILVER CORP. (AG: NYSE; FR: TSX) (das „Unternehmen“ oder „First Majestic”) freut sich, die ungeprüften Konzernzwischenergebnisse des Unternehmens für